When medicine supply chains become weapons: China’s leverage and how the U.S. should respond Pharmaceutical & Drug Policy When medicine supply chains become weapons: China’s leverage and how the U.S. should respond Marta E. Wosińska March 19, 2026
Marta Wosińska’s testimony before the House Select Committee on the Chinese Communist Party Pharmaceutical & Drug Policy Marta Wosińska’s testimony before the House Select Committee on the Chinese Communist Party Marta E. Wosińska March 18, 2026
The economic value of policies and programs to support children’s mental health Mental Health & Well-Being The economic value of policies and programs to support children’s mental health Richard G. Frank, Chloe Zilkha March 17, 2026
Comments on the proposed 2027 Notice of Benefit and Payment Parameters Health Care Policy Comments on the proposed 2027 Notice of Benefit and Payment Parameters Matthew Fiedler March 16, 2026